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Objective: This study aimed to examine levels of depression and quality of life in Spanish-speaking (less acculturated)
immigrants with epilepsy compared with those in English-speaking US-born persons with epilepsy (PWEs).
Methods: The study included 85 PWEs— 38 Spanish-speaking immigrants with epilepsy and 47 US-born PWEs. All
patients underwent video-EEGmonitoring and completeddepression and quality-of-life inventories in their dom-
inant language (Spanish/English). Chart review of clinical epilepsy variables was conducted by an epileptologist.
Results:Our study revealed that depression scoreswere signiﬁcantly higher inHispanic PWEs (21.65± 14.6) than
in US-born PWEs (14.50 ± 10.2) (t (64.02) = −2.3, two-sided p = .025). Marital status, medical insurance,
antidepressant use, seizure frequency, and number of antiepileptic drugs (AEDs) were tested as covariates in
the ANCOVA framework and were not statistically signiﬁcant at the 0.05 signiﬁcance level.
Fewer Hispanics were prescribed antidepressant medications (13.15% for Hispanics and 40.42% for US-born,
χ2 (1,85) 7.71, p = .005) and had access to comprehensive health insurance coverage (χ2 (1,85) = 13.70,
p = 0.000). Hispanic patients were also found to be receiving signiﬁcantly less AEDs compared with their
US-born peers (t (83, 85) = 2.33, p = .02). Although quality of life was diminished in both groups, Seizure
Worry was worse for Hispanics after accounting for potential effects of marital status, medical insurance, use of
antidepressants, seizure frequency, and number of antiepileptic drugs (AEDs) ((1, 83), F = 7.607, p = 0.007).
Signiﬁcance: The present study is the ﬁrst of its kind to examine depression and quality of life in Spanish-speaking
US immigrants with epilepsy. Spanish-speaking immigrants with epilepsy have been identiﬁed as a group at risk.
They demonstrated higher depression scores and more SeizureWorry independent of epilepsy and demographic
characteristics compared with their US-born peers. The Hispanic group was receiving less treatment for depres-
sion, was taking less AEDs, and had less access to comprehensive health coverage compared with non-Hispanics.© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The prevalence of depression in persons with epilepsy (PWEs) is
higher than in matched healthy populations, with ﬁgures ranging
from 11 to 62% [1,2]. In fact, numbers are suspected to be even greater
because of underdiagnosing as PWEs are not regularly screened for
depression [3]. Accurate recognition of this comorbidity is particularly
important because it has the potential to diminish quality of life [4],
lead to impoverished health outcomes [5], and it has been associatedsy Group, 820 Second Avenue,
0; fax: +1 212 661 7496.
).
. This is an open access article underwith signiﬁcantly higher suicide rates [6]. There are a number of factors
that contribute to poor quality of life in PWEs, including health (seizure-
speciﬁc) worries, social stigma, as well as depression [7–9].
The Hispanic population of the United States is estimated to be 52
million, 16.7% of the total US population [10]. Over half (53.1%) of the
foreign-born US population originates from Latin America and the Ca-
ribbean, and as such represents a substantial subgroup. Hispanics in
the US, regardless of migration status, have been identiﬁed as a high-
risk group for depression along with other mental health ailments
[11]. It is speculated that the stressful experiences immigrants encoun-
ter, including linguistic, ﬁnancial, acculturative, legal, and discriminato-
ry challenges, contribute to poorer mental health [12].
To our knowledge, the only other study investigating depression and
quality of life in Hispanics with epilepsy in the US examined PWEs ofthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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[13]. The study concluded that there were differences in rates of de-
pression, perceptions of stigma, and quality of life based on different
levels of acculturation. Predominantly Spanish-speaking immigrants
with epilepsy have not been studied. It is important to study this sub-
group because they may differ on acculturation rates from US-born
and English-speaking Hispanics as acculturation closely relates to mas-
tery of the host culture's language [14]. Lacking sufﬁcient knowledge of
the host culture's language has the potential to increase this group's
vulnerability when additional barriers to health care are encountered
and the patients are not able to properly communicate with their
health-care providers [15].
The purpose of the present study was to assess the levels of depres-
sion and quality of life in Spanish-speaking US-Hispanic immigrants
compared with English-speaking US-born PWEs. The main hypothesis
of this study was that Hispanic immigrant PWEswould exhibit elevated
depression and lower quality-of-life scores compared with US-born
PWEs after controlling for epilepsy and demographic variables. Gaining
a clearer understanding of potential mental health problems in this
large and growing portion of the US population contributes important
clinical information for treatingneurologists andmental healthworkers.
2. Methods
2.1. Subjects
This study included 93 consecutive patients with a diagnosis of
epilepsy conﬁrmed through inpatient video-EEG monitoring, who also
underwent a comprehensive neuropsychological battery between
2006 and 2011. Neuropsychological testing was requested as part of a
presurgical workup or because there was a need to characterize cogni-
tive complaints (i.e., memory or language deﬁcits). Of these, 45 were
Hispanic immigrants from Central and South America, as well as the
Caribbean,whowere Spanish-dominant and required testing in Spanish
by a bilingual neuropsychologist. The ﬁrst forty-eight consecutive US-
born, English-speaking patients were included.
2.2. Procedures
The Hispanic immigrant patients were tested and interviewed by
Spanish-speaking neuropsychologists (LM, MB, and GV) who adminis-
tered a neuropsychological battery as well as two self-report measures:
the Beck Depression Inventory (BDI-II) and the Quality of Life in Epilep-
sy Inventory-31 (QOLIE-31). The following variables were determined
through chart review by an epileptologist (ML) who was blind to group
membership: epilepsy type and syndrome, etiology, epilepsy surgery
(yes/no), seizure frequency, age at onset, and duration of seizures. Anti-
epileptic drugs (AEDs) were also tallied for each patient. Seizure fre-
quency was deﬁned by the total number of seizures in the six months
prior to neuropsychological testing. For the purpose of the analysis,
simple partial seizures were not counted.
Demographic information, including health insurance, marital and
working status, education, as well as current prescription of antidepres-
sants, was gathered through neuropsychological clinical interviews and
chart review. To determine socioeconomic status, we used two proxies:
health insurance as well as median household income of their postal
zone, as reported by the U.S. Census Bureau [16]. Health insurance
was categorized as follows: uninsured/Medicaid and Medicare/private
(i.e., HMOs, PPOs, etc.). Additionally, country of origin and sum of
years of residence in the US were collected for the Hispanic sample.
Four Puerto Rican patients were included as Hispanic immigrants be-
cause they had moved to the mainland less than two years prior to
the assessment and spoke only Spanish.
The initial number of 93 patients was reduced to 86 after the fol-
lowing exclusions: two in the Hispanic sample were found to have a
dual diagnosis of epilepsy and PNESs, and ﬁve scored less than 70 onthe aggregate IQ scale as assessed by the cognitive batteries (one was
English-dominant and ﬁve were Spanish-dominant). A total of 38
Spanish-speaking immigrants and 47 US-born patients were included
in the ﬁnal sample.
The standard battery of tests administered to our Spanish-speaking
patients at the Northeast Regional Epilepsy Group includes cognitive
tests that are part of the Neuropsychological Screening Battery for
Hispanics (NeSBHIS) as well as a measure of intelligence (Batería III
Woodcock–Muñoz). English-speaking patients were administered a
comprehensive neuropsychological battery, including an intelligence
test (WASI) as well as other cognitive measures of language, memory,
attention, and motor skills. The patients also completed two self-report
measures, which assessed depression and quality of life in epilepsy.
The Batería III Woodcock–Muñoz is the Spanish adaptation of the
Woodcock–Johnson III® (WJ III®) [17]. The cognitive battery produces
scores on six major scales, of which one is the Brief Intellectual Ability
(BIA) Score. The BIA represents an average of three subtests: Verbal
Comprehension (Comprensión Verbal), Concept Formation (Formación
de Conceptos), and Visual Pairing (Pareo Visual). Normative data for the
test were gathered from 8818 subjects in over 100 geographically
diverse communities in the United States. Reliability of the measure is
excellent in that most of theWJ III tests show strong reliabilities of .80
or higher; several are .90 or higher. For the purpose of this study, the
BIA score was utilized as a criterion for exclusion (BIA b 70). At this
time, this test represents the only availablemeasure of intellectual func-
tioning for Spanish-speaking test takers in the US that has been shown
to have acceptable validity and reliability scores.
The Wechsler Abbreviated Scale of Intelligence (WASI) consists of
four subtests: Vocabulary, Similarities, Block Design, and Matrix Rea-
soning. The four-subtest form produces Full Scale (FSIQ) scores [18].
For the purpose of this study, FSIQ was utilized as a criterion for exclu-
sion (FSIQ b 70). TheWoodcock–Johnson versions and theWechsler in-
telligence versions can be considered comparable as they have shown
equally strong reliabilities and validities, and commonalities between
both tests have been determined regarding the Full Scale IQ and the
Broad Cognitive Ability score [19].
The Beck Depression Inventory — II (BDI-II) is a 21-item, self-report
rating inventory measuring characteristic attitudes and symptoms of
depression [20]. Internal consistency for the BDI-II ranges from .73 to
.92 with a mean of .86. Answers are scored on a 0 to 3 scale (minimal:
0 and severe: 3). Scores are interpreted as:mild depression (b15),mod-
erate depression (15–30), and severe depression: (N30). The BDI-II was
translated into Spanish in 1996, and its reliability has been demon-
strated with medical samples [21].
The Quality of Life in Epilepsy Inventory (QOLIE-31) is a 31-question
inventory designed to measure an adult's quality of life and asks about
several aspects of health [22]. Its seven scales assess emotional well-
being, social functioning, energy/fatigue, cognitive functioning, worry
about seizures, medication effects, and overall quality of life (a single
10-point Likert item). A weighted average of the multi-item scale scores
is used to obtain a total score. Additionally, the inventory utilizes a single
item to assess overall health. When scoring, a higher t-score indicates a
more desirable quality of life. The test is designed speciﬁcally for people
with epilepsy and, as such, addresses issues as driving, seizures, andmed-
ication. The QOLIE-31 has been translated into nine languages, including
Spanish. For the QOLIE-31, quality of life was determined to be dimin-
ished if the scale fell less than 1.5 standard deviations below the mean.
Internal Review Board (IRB) approval for an anonymous archival re-
cord review was obtained with removal of non-relevant PHI (Coperni-
cus IRB NRE1-11-155).
2.3. Data analysis
Categorical demographic data and medical characteristics were
compared between ethnic groupswith the chi-square test. Quantitative
continuous variables were examined with independent t-tests. Pearson
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residence in the US (for Hispanic immigrants) and the BDI-II and QOLIE
scores.
The effect of ethnicity on depression levels was analyzed within the
framework of analysis of covariance (ANCOVA).We startedwith the full
model, with the BDI score as the dependent variable. The predictors
were ethnic group and several other covariates with predictive poten-
tial, includingmarital status, medical insurance, antidepressant use, sei-
zure frequency, and number of antiepileptic drugs. We then developed
the best ANCOVA model using the backward stepwise selection proce-
dure. At each step, we dropped the least statistically signiﬁcant predic-
tor until all the predictors in the model were statistically signiﬁcant.
There was one exception: the variable of ethnic group had immunity
and was never dropped, since the effect of ethnicity is the focus of our
analysis. The statistical signiﬁcance of each predictor was determined
using the corresponding F-test. We noticed that, in the ﬁnal ANCOVA
model, ethnic group was the only predictor left. On the other hand,
Levene's test for the equality of variances between the two groups indi-
cated that the variances were unequal, and the ANCOVA F-test for pre-
dictor ethnic group was imprecise. At this stage, we switched to the
independent samples t-test for ethnic group assuming unequal vari-
ances. We drew conclusions based on this test.
When analyzing quality of life in relation to ethnic group, weworked
with six quality-of-life subscales: Seizure Worry, Emotional Well-being,
Energy, Cognitive,Medical Effects, and Social.We had to account for sev-
eral potentially important covariates, including marital status, medical
insurance, antidepressant use, seizure frequency, and number of AEDs.
Therefore, we developed the optimalmultivariate analysis of covariance
(MANCOVA)model for quality of life the sameway the optimal ANCOVA
model for depression was developed. We used backward stepwise se-
lection and gave immunity to the ethnic group variable. The statistical
signiﬁcance of each predictor was determined using the corresponding
Wilks Lambda test. To assess the goodness of the optimal MANCOVA
model, we paid attention to Box's test of equality of covariancematrixes
and Wilks Lambda goodness of ﬁt test. We drew an inference about
potential effects of ethnicity based on the Wilks Lambda test for group
in the optimal model. We proceeded to calculate Cronbach's alpha to
check the reliability of the six quality-of-life subscales and followed up
with their bivariate correlations. We noticed that each of the subscales
had a substantial amount of original information which prompted us
to run a separate univariate ANCOVA analysis for each subscale. We
did this in the same fashion we analyzed depression. However, since
we were performing multiple testing, we applied the Bonferroni ad-
justment and decreased the signiﬁcance level for each ANCOVA F-test
to 5%/6 = 0.833%. In the optimal ANCOVA model, we paid attention to
Levene's test of the equality of variances and the goodness of ﬁt F-test.
We drew an inference using the F-test for variable ethnic group.3. Results
There were 38 Hispanic immigrant patients, including 14 males and
24 females. There were 47 non-Hispanic PWEs, including 16 males and
31 females. A signiﬁcant difference in antidepressant usewas found be-
tween the groups (12.82% for Hispanics and 43.48% for US-born, χ2Table 1a
Qualitative demographic and clinical variables.
US-born Hispanic
immigrant
df, χ2 p
Employed? (yes/no) 13/34 11/27 1, 0.01 .896
Marital status (in a relationship, not in
a relationship)
28/19 17/21 1, 1.85 .173
Currently on antidepressants? (yes/no) 19/28 5/33 1, 7.71 .005⁎⁎
Sex (male/female) 16/31 14/24 1, 0.07 . 78
⁎⁎ Signiﬁcant at p b 0.01.(2,85) 10.35, p= .006), withHispanic immigrants reporting signiﬁcant-
ly lower use (Table 1a).
Employment and marital status as well as gender did not differ
between groups (Table 1a). No signiﬁcant differences were found in
terms of age, age at onset, years with epilepsy, and seizure frequency
between the two groups (Table 1b). However, a signiﬁcant differ-
ence in education was found between the groups (t (83, 85) = 3.61,
p = .001) showing that the Spanish-speaking Hispanics had less for-
mal education. A signiﬁcant difference was also identiﬁed regarding
number of AEDs, with Hispanic patients receiving signiﬁcantly less
AEDs compared with their US-born peers (t (83, 85) = 2.33, p = .02).
(Table 1b). No signiﬁcant differences were noted between groups in
terms of epilepsy types and surgical status (Table 2).
A statistically signiﬁcant difference was observed between the two
groupswith respect to the two socioeconomic proxies: health insurance
coverage (χ2 (1,85) = 13.70, p = 0.000),with more Medicaid coverage
and uninsured status for the Hispanic immigrants (Table 3), and me-
dian household income based on their postal zone (t (83, 85) = 3.478,
p = 0.001).
Twenty-four of 38 Hispanic depression scores fell in the moderate/
severe range, whereas 13 of 47 of the control group depression scores
fell in the moderate/severe range. The optimal ANCOVA model for
depression rates (BDI) contained only the ethnic group variable. The
other variables including marital status, medical insurance, antidepres-
sant use, seizure frequency, and number of AEDs were dropped during
the backward stepwise selection as statistically nonsigniﬁcant. In the
ﬁnal ANCOVA model, Levene's test indicated that the variances were
unequal (p-value=0.023), sowe switched to the independent samples
t-test assuming unequal variances. According to this test (two-sided
p-value = 0.025), the two ethnic groups had depression levels that
were different than expected. In fact, based on the estimates, Hispanics
were more depressed on average.
Quality of life was diminished (deﬁned as ≤1.5 standard deviations)
regardless of group of origin. The optimal MANCOVA model for quality
of life contained the following predictors: insurance (p-value= 0.011),
current antidepressant use (p-value = 0.01), and ethnic group (p-
value = 0.054). Since ethnic group was only marginally signiﬁcant,
we did not view the MANCOVA results as deﬁnitive. We concluded
that MANCOVA should be run on a bigger data set. Chronbach's alpha
on the six quality-of-life subscales equals 0.763, indicatingmoderate re-
liability, whichmeans that each of the subscales contained a substantial
amount of original information. This conclusionwas conﬁrmed by the bi-
variate correlations of subscales, which were of the order 0.3–0.5 when-
ever they were statistically signiﬁcant. Clearly, the subscales were not
telling us the same thing and had to be analyzed separately, within the
framework of ANCOVA. Only for one of the subscales, Seizure Worry,
was ethnic group statistically signiﬁcant in the optimal ANCOVA model
(p-value=0.007 b 0.00833). Note that the p-value falls below the signif-
icance level even after the Bonferroni adjustment. We see that quality of
life, as measured by Seizure Worry, was lower for Hispanics on average.
The model was reliable because Levene's test was passed (p-value =
0.511), and the goodness of ﬁt was achieved automatically because
there was only one categorical predictor in the model (ethnic group).Table 1b
Quantitative demographic and clinical variables.
Hispanics US-born t-Score p
Age 43.44 ± 13.92 40.72 ± 11.71 t =− .980 p = .20
Age at onset 24.89 ± 18.30 18.89 ± 14.66 t =−1.67 p = .09
Years with epilepsy 19.58 ± 12.40 21.83 ± 13.45 t = .79 p = .43
Number of AEDs 1.79 ± 0.84 2.26 ± 0.96 t = 2.33 p = .02a
Years of education 10.84 ± 2.94 12.98 ± 2.50 t = 3.61 p = .001a
Seizure frequency
(seizure/month)
2.11 ± 3.67 2.52 ± 6.51 t = 0.346 p = .73
a df = 83.
Table 2
Comparison of epilepsy characteristics between groups.
Hispanics US-born df, χ2 p
Epilepsy type
Partial epilepsy 33 38 1, 0.54 0.46
Temporal lobe epilepsy 17 25 1, 0.60 0.44
Frontal lobe epilepsy 3 1
Occipital lobe epilepsy 0 3
Undetermined 13 9
Generalized epilepsy 5 9 1, 0.54 0.46
Lesional 11 17 1, 0.49 0.48
Surgical (yes) 10 20 1, 2.42 0.11
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nic group, with the Bonferroni adjustment or without.
For the Hispanic group, time in the US did not correlate with the
BDI-II score (r = .091, p = .59), or with any of the QOLIE-31 scales.
4. Discussion
Our study identiﬁed that a substantial number (61.6%) of Spanish-
speaking immigrant PWEs reported clinical range (moderate to severe)
depression as measured by the BDI-II compared with 28.3% US-born
PWEs in this range. Moreover, the Hispanic group continued to exhibit
signiﬁcantly greater depression even after accounting for marital status,
medical insurance, antidepressant use, seizure frequency, and number
of AEDs. These ﬁndings are critical given that depression is themost fre-
quent psychiatric comorbidity in PWEs [23] with higher risks of suicidal
ideation and suicide attempts than the general population [24]. Two
recent studies examined depression in Spanish-speaking samples with
epilepsy in Spain and Argentina utilizing the Neurological Depression
Disorders Inventory in Epilepsy (NDDI-E) [25,26]. The Argentinian
study found that 16% of their sample met the Diagnostic and Statistical
Manual, Fourth Edition (DSM-IV) criteria formajor depressive episodes,
while 20% of the Spanish samplemet the same criteria. Their studies and
ours differed with respect to the self-report inventory; however, both
theNDDI-E and the BDI-2 have shown similarly satisfactory clinical util-
ity in assessing depressive symptoms. This suggests that it is less likely
that dissimilarities in depression rates between these international
studies and the present one are primarily the result of the measures
[27], but rather, the observed difference may be at least partially ex-
plained by the migrant status that characterizes our Hispanic sample.
These ﬁndings underscore that an already vulnerable group of patients
in terms of mood disorders [28] – persons with epilepsy –may be at an
even greater risk when they are predominantly Spanish-speaking, His-
panic immigrants. Furthermore, our study identiﬁed signiﬁcantly less
antidepressant use in Hispanic PWEs compared with US-born PWEs.
Despite PWEs, in general, receiving less antidepressant drug treatment
due to misconceptions about their safety in epilepsy [29] and insufﬁ-
cient screening for depression [3], the Hispanic Spanish-speaking
group appeared to be at a higher risk for not receiving this mode of
treatment. One plausible explanation could have been that the individ-
uals in our Spanish-speaking group exhibited higher depression as a
result of receiving less treatment although this was not found to be
the case. Instead, these ﬁndings are consistent with studies that have
identiﬁed signiﬁcantly greater depression care needs in racial and eth-
nic minorities [12] along with signiﬁcantly less provision of depression
care [30,31]. There are likely a multitude of reasons for this discrepancyTable 3
Insurance status between groups.
US-born Hispanic immigrants
Uninsured/medicaid 11 24
Medicare/private insurances 36 14
χ2 = 13.70, p = .000.between depression scores and psychopharmacological treatment in-
cluding insufﬁcient health-care coverage as suggested by the Center
for Disease Control and Prevention Surveillance Summaries [32]. Point
in fact, we found that ourHispanic immigrant groupdiffered signiﬁcant-
ly from the US-born group on health insurance coverage. Sixty-three
percent of the sample was either uninsured or covered by Medicaid.
A recent report highlighted another potential problem which involves
lower health insurance acceptance (private, Medicare, and Medicaid)
in psychiatry [33] compared with other medical specialties. This could
evidently contribute to limited access to psychiatric care in Hispanics
of lower socioeconomic status (SES) who are uninsured or covered by
less comprehensive health plans. However, other potential contributors
to this discrepancy may rest on language dominance since higher risks
of depression undertreatment have been associated with Latinos who
are not English-dominant [34,35] and stigma associated with depres-
sion and psychiatric treatment among Hispanics [36].
Hispanic immigrants in our sample were also receiving signiﬁcantly
less AEDs compared with US-born PWEs even though the two groups
did not differ on epilepsy variables (age at onset, years with epilepsy,
and seizure frequency).We suspect that differences in insurance cover-
agemay account for this partially even though a recent survey of health-
care utilization in Hispanic PWEs in Yuma County, Arizona found that
underutilization of epilepsy-related health services could not be fully
explained by insurance or setting of care [37]. Another possible explana-
tion may rest on language barriers between the patient and the health-
care provider.
In our sample, both immigrant and US-born PWEs reported dimin-
ished quality of life including problems with emotional and cognitive
functions and other life concerns. This is consistent with reports of
diminished QOL in PWEs [38]. Spanish-speaking PWEs exhibited signif-
icantly worse scores on the Seizure Worry Scale of the QOLIE-31 inde-
pendent of epilepsy and demographic characteristics. This subscale
assesses for fears of having a seizure in the near future, embarrassment
associated with having witnessed seizures, and worrying about hurting
oneself during a seizure. Previous reports have found that achieving
better control of seizures [39] plays an important role in quality of life
in epilepsy. From a cultural perspective, it could be speculated that the
stigmatization and misinformation about epilepsy and seizures in
the Hispanic culture might contribute to Hispanic patients' increased
anxiety and embarrassment surrounding seizure occurrence or fearful-
ness regarding seizures themselves. However, this may also represent a
realistic concern in these patients since they were found to be receiving
signiﬁcantly less AEDs compared with their US-born counterparts.
To our knowledge, the only other study of depression and quality of
life in Hispanic PWEs living in the United States examined an English-
speaking Mexican-American sample [13]. Results from that study
underscored the importance acculturation levels can have on depres-
sion, perception of stigma, and QOL in Hispanic PWEs. Our study differs
in several respects: it was composed of Spanish-speaking immigrants,
while the previous study enrolled English-speaking patients, of which
66% “had always lived in the US.” English proﬁciency is an important
variable to consider with regard to acculturation aswell as representing
a potential barrier to adequate health-care access. The inability to com-
municate directly with health-care professionals can be an obstacle
when attempting to conﬁde intimate psychological problems. In addi-
tion, our sample originated not only from Mexico but also from a
range of Latin American countries. Although “Hispanic” is used as an
umbrella term for all people who are somehow related to Spain or to
Spanish-speaking locations, “Hispanics” are in fact from a variety of
very different countries. Including people of multiple Latin American or-
igins, therefore, increases the representativeness of our sample. The
third unique aspect of our study includes a subsequent comparison
that was performed between Spanish-speaking immigrant patients
and US-born English-speaking patients.
The principal limitation to our study is with regard to small sample
size. Another limitation is the absence of more precise information on
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ed or undocumented), and formal acculturation levels as they could have
an impact onmood and quality of life [40]. Our attempts to indirectly as-
sess SES and documentation status through analysis of zip codes and the
collection of health insurance information since typically, undocument-
ed persons are prohibited from receiving federal beneﬁts could be im-
proved in future studies through direct assessments such as health
insurance and federal beneﬁts tend to be for the less afﬂuent. Thehetero-
geneity of our Spanish-speaking sample in terms of country of origin and
culture might be considered by some as a limitation; however, it is rep-
resentative of the Hispanic population in the northeast of the US. We
have also been left with an unanswered question as to why our Hispanic
patients had such limited English proﬁciency despite being in the US for
an average of 16.71 years. In these patients, it is possible that lifetime de-
pression, poverty, less educational attainment, and the tendency for im-
migrants to choose to live in circumscribed locations where there is less
need to speak the host languagemight explain the limited knowledge of
English. Cognitive deﬁcits associated with epilepsy and seizure factors
might also be responsible for limited acquisition of a second language,
but this is beyond the scope of this paper.
Future research might aspire to collect larger samples in which it
might be possible to compare two Hispanic subsamples on depression
and quality of life: presurgical versus nonsurgical patients who are re-
ferred for neuropsychological testing for cognitive complaints. An im-
portant future research direction in Hispanic epilepsy samples could
examine the “immigrant paradox” that has been reported in psychiatry
research and which refers to a ﬁnding that immigrant Hispanics tend to
report lower rates of most psychiatric disorders across mood, anxiety,
and substance disorders compared with US-born Hispanics [11]. This
would require examination of PWEswho are Hispanic immigrants com-
pared with US-born Hispanics.
An additional future direction of investigation may examine the
mental health and quality of life of Hispanic immigrants with epilepsy
comparedwith Hispanics with epilepsy living in their country of origin.
This might be especially useful in light of differences in depression rates
reported in recent Argentinian and Spanish studies [25,26]. The impact
of migration could potentially lower the threshold for mental illness in
certain vulnerable individuals as reported in a recent general psychiatry
study of greater depressive and anxious disorders inmigrants compared
with relatives who remained back in the homeland [41].5. Conclusion
The high prevalence of depression and elevated seizure concerns in
Spanish-speaking Hispanic PWEs compared with US-born PWEs under-
scores two substantial challenges being faced by this subgroup. These
ﬁndings are ampliﬁed in severity because Spanish-speaking PWEs were
also found to have signiﬁcantly less comprehensive health insurance
coverage (or none) and received lower rates of AEDs as well as fewer
antidepressant medications than the comparison group. These results
highlight that Spanish-speaking PWEs are a high-risk population for
undertreatment of signiﬁcant depressive comorbidity and quality-of-
life problems. Screening of psychological health in Spanish-speaking im-
migrant PWEs should be routinely conducted and, better yet, whenever
possible in their dominant language, provide improved health outcomes
and equality of care.Disclosure
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